"This will evolve pretty rapidly," said the company's CEO, who has ties to UC Berkeley.

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Soleno Therapeutics, Inc. (NASDAQ: SLNO) to Neurocrine Biosciences for $53.00 per share in cash.

Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following ...

Google has issued an update alert for 3.5 billion Chrome browser users following confirmation of a new zero-day attack ...

Google has issued a security alert to Chrome users after confirming that cybercriminals had exploited a vulnerable system, ...

During the war in the Gaza Strip and two wars with Iran in the space of a year, Israel has used artificial intelligence to ...

Davidson County residents now have a new way to stay informed during severe weather and other emergencies as the county has ...

Michigan State’s Tom Izzo said Wednesday on “The Dan Patrick Show” that he considered coaching the Phoenix Suns after ...

Four astronauts are awaiting liftoff on humanity's first flight to the moon in more than half a century. The 32-story rocket ...